ADDS changed its name : Advanced Drug and Device Services Since 1st January 2012, ADDS changed its na...
ADDS is investing by taking a 25% stake in the Pan-European Services Provider : JSW-Clinical Investigat...
Our European CRO offers pharmaceutical, biotech and medtech companies full coverage of Phase II-III and late phase clinical studies for drugs and medical devices in Western and Central Europe through our offices in France and Czech Republic, as well ...
As a European CSO, ADDS provides coverage of all vigilances and risk management issues. Our Safety and Risk management department offers full services in pre and post marketing Risk management and the outsourcing of your Pharmacovigilance services, i...